The predominance of MLH1/PMS2 loss in sporadic cases suggests a key role for epigenetic silencing in initiating genomic instability; however, the absence of MMR deficiency in the majority of atypical hyperplasia cases implies that alternative driver mutations may contribute to neoplastic transformation. This evidence concerns the gene MLH1 and hyperinsulinemic hypoglycemia, familial, 4.